| Risk | Moderately High |
|---|---|
| Min SIP Amount | ₹500 |
| Expense Ratio | 0.98% |
| NAV | ₹26.76 (22 Oct 2020) |
|---|---|
| Fund Started | 24 Feb 2014 |
| Fund Size | ₹1,655 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Max Financial Services Ltd. | Financial | Equity | 8.6% |
| Endurance Technologies Ltd. | Automobile | Equity | 7.7% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 6.5% |
| PI Industries Ltd. | Chemicals | Equity | 6.3% |
| Abbott India Ltd. | Healthcare | Equity | 4.9% |
| Crompton Greaves Consumer Electricals Ltd. | Cons Durable | Equity | 4.7% |
| Coromandel International Ltd. | Chemicals | Equity | 4.4% |
| Metropolis Healthcare Ltd. | Healthcare | Equity | 3.8% |
| Voltas Ltd. | Cons Durable | Equity | 3.7% |
| Avenue Supermarts Ltd. | Services | Equity | 3.7% |
Motilal Oswal Midcap 30 Fund Direct Growth is a Equity Mutual Fund Scheme launched by Motilal Oswal Mutual Fund. This scheme was made available to investors on 24 Feb 2014. Abhiroop Mukherjee, Akash Singhania, Siddharth Bothra is the Current Fund Manager of Motilal Oswal Midcap 30 Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹1,655 Cr and the Latest NAV as of 22 Oct 2020 is ₹26.76.
The Motilal Oswal Midcap 30 Fund Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 500. Exit load of 1% if redeemed within 15 days
The scheme seeks to achieve long term capital appreciation by investing in a maximum of 30 quality mid cap companies having long-term competitive advantages and potential for growth.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.